Skip to main content
. 2023 Apr 19;15(1):25–32. doi: 10.4103/ijt.ijt_5_22

Table 9.

Comparison of various studies using low-level laser therapy in androgenetic alopecia

Study Sample size Grade of AGA Intervention Result (mean increase in hair density in LLLT and control group)
Leavitt et al., 2009[13] 110 male patients Norwood–Hamilton 2-5 HairMax LaserComb, 655± (5%) nm for 26 weeks LLLT group: 19.8 hairs/cm2 Control (sham) group: −7.6 hairs/cm2
Kim et al., 2013[14] 40 male and female patients Norwood–Hamilton 3-6 Ludwig 1 and 2 Helmet type LLLT device, 650 nm laser with 630 and 660 nm LEDs for 24 weeks LLLT group: 17.2 hairs/cm2 Control (sham) group: −2.1 hairs/cm2
Lanzafame et al., 2013[15] 44 male patients Norwood–Hamilton 2-5 Helmet (TOPHAT655) 655±5 nm for 16 weeks LLLT group: 67.2 hairs/cm2 Control (sham) group: 32.3 hairs/cm2
Faghihi et al., 2018[16] 50 males and females Norwood–Hamilton 3-6 for male, Ludwig 2-3 for female LDU 8024PN/8024BN, 785-nm wavelength for 24 weeks No significant differences at 3 and 6 months, however, significant difference was found at 9 and 12 months after the intervention LLLT + minoxidil group: 78.3% Minoxidil group: 51.3%
Suchonwanit et al., 2019[17] 40 males and females Norwood–Hamilton 3-5 for male, Ludwig 1-3 for female RAMACAP a combat helmet-shaped device 660±10 nm wavelength for 24 weeks LLLT group: 10.21±3.25 hairs/cm2 Control (sham) group: 3.95±1.32 hairs/cm2
Present study 54 male patients Norwood–Hamilton 2-4 Hairmax LaserComb 655 nm for 16 weeks LLLT+minoxidil group: 34.5 hairs/cm2 Minoxidil group: 24.21 hairs/cm2

ADR – Adverse drug reactions; LLLT – Low-level laser therapy; LEDs – Light emitting diodes